Changes in cancer diagnoses and stage distribution during the COVID-19 pandemic in the United States, 2019-2022.
The study analyzed changes in cancer diagnoses and stage distribution in the US from 2019 to 2022 using data from the Na...
The study analyzed changes in cancer diagnoses and stage distribution in the US from 2019 to 2022 using data from the Na...
You’ve seen the survival gaps. You’ve felt the impact. And the question that follows is both urgent and fair:What exactly can you do about it — in your clinic, with…
You know palliative care isn’t an end-of-life intervention. It’s a proactive, evidence-based system that extends survival, preserves dose intensity, and minimizes avoidable treatment disruptions. So, here's the real question: How…
Checkpoint inhibitors are no longer reserved for late-stage salvage. The clearest signal from recent meetings and trials is this: the greatest survival benefit may be increasingly found in neoadjuvant and perioperative settings. This…
Coming off Colorectal Cancer Awareness Month, the conversation around rising cases, younger patients, and late-stage diagnoses is intensifying. NCCN has updated its guidance. New targeted options—including one approved April 8,…
We escalate for dyspnea. We act on chest pain. But fatigue - the kind that erodes function, adherence, and dignity - is still routinely noted, not treated. That’s no longer…